These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2043 related articles for article (PubMed ID: 28052991)

  • 21. Lipid Metabolic Pathways Confer the Immunosuppressive Function of Myeloid-Derived Suppressor Cells in Tumor.
    Yan D; Adeshakin AO; Xu M; Afolabi LO; Zhang G; Chen YH; Wan X
    Front Immunol; 2019; 10():1399. PubMed ID: 31275326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myeloid-Derived Suppressor Cells in Sepsis.
    Schrijver IT; Théroude C; Roger T
    Front Immunol; 2019; 10():327. PubMed ID: 30873175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of microRNAs on myeloid-derived suppressor cells in cancer.
    Baghbani E; Noorolyai S; Duijf PHG; Silvestris N; Kolahian S; Hashemzadeh S; Baghbanzadeh Kojabad A; FallahVazirabad A; Baradaran B
    Hum Immunol; 2021 Sep; 82(9):668-678. PubMed ID: 34020831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms overseeing myeloid-derived suppressor cell production in neoplastic disease.
    Netherby CS; Abrams SI
    Cancer Immunol Immunother; 2017 Aug; 66(8):989-996. PubMed ID: 28224211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conditioned media from the renal cell carcinoma cell line 786.O drives human blood monocytes to a monocytic myeloid-derived suppressor cell phenotype.
    Okada SL; Simmons RM; Franke-Welch S; Nguyen TH; Korman AJ; Dillon SR; Gilbertson DG
    Cell Immunol; 2018 Jan; 323():49-58. PubMed ID: 29103587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasticity and biological diversity of myeloid derived suppressor cells.
    Ben-Meir K; Twaik N; Baniyash M
    Curr Opin Immunol; 2018 Apr; 51():154-161. PubMed ID: 29614426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myeloid-Derived Suppressor Cells in Cancers and Inflammatory Diseases: Angel or Demon?
    Su Z; Ni P; Zhou C; Wang J
    Scand J Immunol; 2016 Nov; 84(5):255-261. PubMed ID: 27541573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myeloid-derived suppressor cells and tumor: Current knowledge and future perspectives.
    Safari E; Ghorghanlu S; Ahmadi-Khiavi H; Mehranfar S; Rezaei R; Motallebnezhad M
    J Cell Physiol; 2019 Jul; 234(7):9966-9981. PubMed ID: 30537008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutualistic Effects of the Myeloid-Derived Suppressor Cells and Cancer Stem Cells in the Tumor Microenvironment.
    Tanriover G; Aytac G
    Crit Rev Oncog; 2019; 24(1):61-67. PubMed ID: 31679221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-17 inhibits the accumulation of myeloid-derived suppressor cells in breast cancer via activating STAT3.
    Ma M; Huang W; Kong D
    Int Immunopharmacol; 2018 Jun; 59():148-156. PubMed ID: 29655056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunomodulatory effects of myeloid-derived suppressor cells in diseases: Role in cancer and infections.
    Tamadaho RSE; Hoerauf A; Layland LE
    Immunobiology; 2018; 223(4-5):432-442. PubMed ID: 29246400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human neutrophils: Their role in cancer and relation to myeloid-derived suppressor cells.
    Moses K; Brandau S
    Semin Immunol; 2016 Apr; 28(2):187-96. PubMed ID: 27067179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. microRNAs Shape Myeloid Cell-Mediated Resistance to Cancer Immunotherapy.
    Daveri E; Vergani E; Shahaj E; Bergamaschi L; La Magra S; Dosi M; Castelli C; Rodolfo M; Rivoltini L; Vallacchi V; Huber V
    Front Immunol; 2020; 11():1214. PubMed ID: 32793185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The immunobiology of myeloid-derived suppressor cells in cancer.
    Motallebnezhad M; Jadidi-Niaragh F; Qamsari ES; Bagheri S; Gharibi T; Yousefi M
    Tumour Biol; 2016 Feb; 37(2):1387-406. PubMed ID: 26611648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity.
    Veglia F; Sanseviero E; Gabrilovich DI
    Nat Rev Immunol; 2021 Aug; 21(8):485-498. PubMed ID: 33526920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses.
    Hossain F; Majumder S; Ucar DA; Rodriguez PC; Golde TE; Minter LM; Osborne BA; Miele L
    Front Immunol; 2018; 9():1288. PubMed ID: 29915603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activated NKT cells facilitated functional switch of myeloid-derived suppressor cells at inflammation sites in fulminant hepatitis mice.
    Wu D; Shi Y; Wang C; Chen H; Liu Q; Liu J; Zhang L; Wu Y; Xia D
    Immunobiology; 2017 Feb; 222(2):440-449. PubMed ID: 27523745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myeloid-derived suppressor cells as effectors of immune suppression in cancer.
    Pyzer AR; Cole L; Rosenblatt J; Avigan DE
    Int J Cancer; 2016 Nov; 139(9):1915-26. PubMed ID: 27299510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The diversity of circulating neutrophils in cancer.
    Mishalian I; Granot Z; Fridlender ZG
    Immunobiology; 2017 Jan; 222(1):82-88. PubMed ID: 26874580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting Suppressive Myeloid Cells Potentiates Checkpoint Inhibitors to Control Spontaneous Neuroblastoma.
    Mao Y; Eissler N; Blanc KL; Johnsen JI; Kogner P; Kiessling R
    Clin Cancer Res; 2016 Aug; 22(15):3849-59. PubMed ID: 26957560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 103.